Identification of key metabolic changes in renal interstitial fibrosis rats using metabonomics and pharmacology

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Zhao, Liangcai ^a   Dong, Minjian ^a   Liao, Shixian ^a   Du, Yao ^a   Zhou, Qi ^a   Zheng, Hong ^a   Chen, Minjiang ^a   Ji, Jiansong ^a   Gao, Hongchang ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; BRANCHED CHAIN AMINO ACID; INDICAN;

ANIMAL; CHEMISTRY; DISEASE MODEL; DRUG EFFECTS; KIDNEY; KIDNEY DISEASE; MALE; METABOLISM; METABOLOMICS; PROCEDURES; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; SPRAGUE DAWLEY RAT; URINE;

AMINO ACIDS, BRANCHED-CHAIN; ANIMALS; BIOMARKERS; DISEASE MODELS, ANIMAL; INDICAN; KIDNEY; KIDNEY DISEASES; MALE; METABOLOMICS; PROTON MAGNETIC RESONANCE SPECTROSCOPY; RATS; RATS, SPRAGUE-DAWLEY; URINE;

EID: 84973369142     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep27194     Document Type: Article

References (43)

1. Neilson, E. Mechanisms of disease: fibroblasts-a new look at an old problem. Nat Clin Pract Nephrol 2, 101-108 (2006).
2. Ponnusamy, M. et al. Blocking sirtuin 1 and 2 inhibits renal interstitial fibroblast activation and attenuates renal interstitial fibrosis in obstructive nephropathy. J Pharmacol Exp Ther 350, 243-256 (2014).
3. Li, X., Long, Q., Cheng, X. & He, D. Shock wave induces biological renal damage by activating excessive inflammatory responses in rat model. Inflammation 37, 1317-1325 (2014).
4. Grgic, I. et al. Renal fibrosis is attenuated by targeted disruption of KCa3. 1 potassium channels. Proc Natl Acad Sci USA 106, 14518-14523 (2009).
5. Nicholson, J. K., Lindon, J. C. & Holmes, E. 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 29, 1181-1189 (1999).
6. Psihogios, N. G., Gazi, I. F., Elisaf, M. S., Seferiadis, K. I. & Bairaktari, E. T. Gender-related and age-related urinalysis of healthy subjects by NMR-based metabonomics. NMR Biomed 21, 195-207 (2008).
7. Zhao, L. et al. 1H-NMR-based metabonomic analysis of metabolic profiling in diabetic nephropathy rats induced by streptozotocin. Am J Physiol Renal Physiol 300, F947-956 (2011).
8. Guan, M. et al. Systemic perturbations of key metabolites in diabetic rats during the evolution of diabetes studied by urine metabonomics. PLoS One 8, e60409 (2013).
9. 1H-NMR based metabonomic approach. Mol Biosyst 10, 686-693 (2014).
10. Korner, A., Eklof, A. C., Celsi, G. & Aperia, A. Increased renal metabolism in diabetes. Mechanism and functional implications. Diabetes 43, 629-633 (1994).
11. 1H NMR and HPLCTOF MS. Mol Biosyst 1, 166-175 (2005).
12. Zhao, Y. Y. et al. UPLC-Q-TOF/HSMS/MS(E)-based metabonomics for adenine-induced changes in metabolic profiles of rat faeces and intervention effects of ergosta-4,6,8(14),22-tetraen-3-one. Chem-Biol Interact 201, 31-38 (2013).
13. Zhao, Y. Y., Cheng, X. L., Wei, F., Bai, X. & Lin, R. C. Application of faecal metabonomics on an experimental model of tubulointerstitial fibrosis by ultra performance liquid chromatography/high-sensitivity mass spectrometry with MS(E) data collection technique. Biomarkers 17, 721-729 (2012).
14. Zhao, Y. Y. et al. Ultra performance liquid chromatography-based metabonomic study of therapeutic effect of the surface layer of Poria cocos on adenine-induced chronic kidney disease provides new insight into anti-fibrosis mechanism. PLoS One 8, e59617 (2013).
15. Wei, T. et al. Metabonomic analysis of potential biomarkers and drug targets involved in diabetic nephropathy mice. Sci Rep-UK 5, 11998 (2015).
16. 1H NMR metabonomics in predicting renal function recoverability after the relief of obstructive uropathy in adult patients. Clin Biochem 46, 346-353 (2013).
17. 1H NMR-based metabonomics study on serum of renal interstitial fibrosis rats induced by unilateral ureteral obstruction. Mol Biosyst 8, 595-601 (2012).
18. Kilkenny, C., Browne, W. J., Cuthill, I. C., Emerson, M., Douglas, G. & Altman, D. G. Improving bioscience research reporting: The ARRIVE guidelines for reporting animal research. PLoS Biology 8, e1000412 (2010).
19. Zhao, L. et al. Serum metabonomic analysis of protective effects of Curcuma aromatica oil on renal fibrosis rats. PLoS One 9, e108678 (2014).
20. Westerhuis, J. A., van Velzen, E. J., Hoefsloot, H. C. & Smilde, A. K. Multivariate paired data analysis: multilevel PLSDA versus OPLSDA. Metabolomics 6, 119-128 (2010).
21. 1H NMR spectroscopy. J Proteome Res 6, 3456-3464 (2007).
22. 1H NMR spectroscopic metabonomic studies. Anal Chem 77, 517-526 (2005).
23. Zheng, H. et al. Metabolomics investigation to shed light on cheese as a possible piece in the French paradox puzzle. J Arg Food Chem 63, 2830-2839 (2015).
24. Wang, Y. M., You, W. H. & Xiong, Z. Y. Effects of branched-chain amino acids on some biochemical indices in endurance training rats. J Shanxi Norm Univer 41, 93-97 (2013).
25. Maldonado, C., Pushpakumar, S. B., Perez-Abadia, G., Arumugam, S. & Lane, A. N. Administration of exogenous adenosine triphosphate to ischemic skeletal muscle induces an energy-sparing effect: role of adenosine receptors. J Surg Res 181, e15-22 (2013).
26. Saigo, C. et al. Meclofenamate elicits a nephropreventing effect in a rat model of ischemic acute kidney injury by suppressing indoxyl sulfate production and restoring renal organic anion transporters. Drug Des Devel Ther 8, 1073-1082 (2014).
27. Chevalier, R. L., Forbes, M. S. & Thornhill, B. A. Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy. Kidney Int 75, 1145-1152 (2009).
28. Klahr, S. & Morrissey, J. Obstructive nephropathy and renal fibrosis. Am J Physiol Renal Physiol 283, 861-875 (2002).
29. Hewitson, T. D. Renal tubulointerstitial fibrosis: common but never simple. Am J Physiol Renal Physiol 296, F1239-1244 (2009).
30. Salek, R. M. et al. A metabolomic comparison of urinary changes in type 2 diabetes in mouse, rat, and human. Physiol Genomics 29, 99-108 (2007).
31. Turner, N. C. et al. Elevated renal endothelin-I clearance and mRNA levels associated with albuminuria and nephropathy in noninsulin-dependent diabetes mellitus: studies in obese fa/fa Zucker rats. Clin Sci (Lond) 93, 565-571 (1997).
32. Saito, H. Toxico-pharmacological perspective of the Nrf2-Keap1 defense system against oxidative stress in kidney diseases. Biochem Pharmacol 85, 865-872 (2013).
33. Kobayashi, T. et al. Exploration of novel predictive markers in rat plasma of the early stages of chronic renal failure. Anal Bioanal Chem 406, 1365-1376 (2014).
34. Chiang, C. K., Tanaka, T. & Nangaku, M. Dysregulated oxygen metabolism of the kidney by uremic toxins: review. J Ren Nutr 22, 77-80 (2012).
35. Inami, Y. et al. Effect of AST-120 on Endothelial Dysfunction in Adenine-Induced Uremic Rats. Int J Nephrol 2014, 164125 (2014).
36. Malgorzewicz, S., Debska-Slizien, A., Rutkowski, B. & Lysiak-Szydlowska, W. Serum concentration of amino acids versus nutritional status in hemodialysis patients. J Ren Nutr 18, 239-247 (2008).
37. Bednarek-Skublewska, A., Swatowski, A., Wawrzycki, S., Baranowicz-Gaszczyk, I. & Ksiazek, A. Concentrations of branched amino acids: isoleucine, valine, leucine in serum of hemodialysis patients during one-year observation. Ann Univ Mariae Curie Sklodowska Med 57, 322-329 (2002).
38. Holecek, M., Sprongl, L., Tilser, I. & Tichy, M. Leucine and protein metabolism in rats with chronic renal insufficiency. Exp Toxicol Pathol 53, 71-76 (2001).
39. Holecek, M., Sprongl, L., Tilser, I. & Tichy, M. Leucine and protein metabolism after bilateral nephrectomy in rats: the role of hepatic tissue. Res Exp Med (Berl) 200, 53-65 (2000).
40. Shah, S. H. et al. Branched-chain amino acid levels are associated with improvement in insulin resistance with weight loss. Diabetologia 55, 321-330 (2012).
41. D'Antona, G. et al. Branched-chain amino acid supplementation promotes survival and supports cardiac and skeletal muscle mitochondrial biogenesis in middle-aged mice. Cell Metab 12, 362-372 (2010).
42. Kawamura, E. et al. A randomized pilot trial of oral branched-chain amino acids in early cirrhosis: validation using prognostic markers for pre-liver transplant status. Liver Transpl 15, 790-797 (2009).
43. Bassit, R. A. et al. Branched-chain amino acid supplementation and the immune response of long-distance athletes. Nutrition 18, 376-379 (2002).